Cancer Management and Research
Volume 15, 2023 - Issue
Open access
139
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program
Pietro Quaglino1 Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy
, Paolo A Ascierto2 Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy
, Francesca Consoli3 Department of Oncology, ASST Spedali Civili, Brescia, Italy
, Paola Queirolo4 Oncology Division, Policlinico San Martino IRCCS, Genova, Italy, and Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy
, Francesco Spagnolo5 Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
, Maria Francesca Morelli6 Department of Oncology and Dermatological Oncology, Istituto Dermopatico dell’Immacola, Rome, Italy
, Rossana Berardi7 Università Politecnica delle Marche – Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy
, Vanna Chiarion-Sileni8 Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
, Marco Tucci9 Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari ‘Aldo Moro’, Bari, Italy
, Teresa Troiani10 Faculty of Medicine, Second University of Naples, Naples, Italy
, Barbara Melotti11 Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
, Ernesto Rossi12 Medical Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy
, Mario Mandala13 Division of Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy, and University of Perugia, Perugia, Italy
, Gaetana Rinaldi14 UOC Oncologia Medica Aoup Paolo Giaccone, Palermo, Italy
, Ilaria Gioia Marcon15 Novartis Farma S.p.A, Milan, Italy
, Matteo Pizzuti15 Novartis Farma S.p.A, Milan, Italy
& Michele Del Vecchio16 Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyCorrespondence[email protected]
show all
Pages 1271-1281
|
Received 12 Jul 2023, Accepted 25 Oct 2023, Published online: 11 Nov 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.